← The Wire
BLFSNasdaq
BIOLIFE SOLUTIONS INC
Electromedical & Electrotherapeutic Apparatus · DE · CIK 834365
Develops, manufactures, and markets bioproduction products and services for cell and gene therapy
$1.28B
Market cap
$28.30
Last close
-1.3%
1D
+13.7%
5D
3.4M
Volume
Price · last 39 sessions+34.2%
May 4L $20.76 · H $28.67Jun 29
125
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureJun 3, 2026SC 13D/ASC 13D/AMay 22, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 202610-K/A10-K/AApr 28, 20268-KReg FD DisclosureMar 2, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KResults of OperationsJan 12, 20268-KExecutive ChangeJan 9, 20268-KReg FD DisclosureNov 17, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KShareholder VoteAug 21, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 2025DEFA14ADEFA14AJul 8, 2025DEF 14ADEF 14AJul 8, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 202510-K/A10-K/AApr 8, 20258-KExecutive ChangeMar 24, 202510-K10-KMar 3, 20258-KCompany UpdateMar 3, 20258-KCompany UpdateJan 13, 20258-KExecutive ChangeDec 20, 20248-KMaterial Agreement · Acquisition / DispositionNov 20, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KMaterial Agreement · Acquisition / DispositionNov 12, 2024SC 13GSEC SCHEDULE 13GNov 8, 202410-Q10-QAug 9, 20248-K/AResults of OperationsAug 9, 20248-KResults of OperationsAug 8, 20248-KShareholder VoteAug 6, 2024DEFA14ADEFA14AJul 26, 2024DEF 14ADEF 14AJun 5, 202410-Q10-QMay 10, 20248-KResults of OperationsMay 9, 20248-KMaterial Agreement · Acquisition / DispositionApr 23, 20248-KExit / Disposal Costs · Company UpdateApr 18, 202410-K10-KFeb 29, 20248-KCompany UpdateFeb 29, 2024SC 13GSC 13GFeb 2, 20248-KResults of OperationsJan 8, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 9, 20238-KExecutive Change · Results of OperationsOct 23, 20238-KMaterial Agreement · Equity IssuanceOct 19, 2023SC 13GSC 13GSep 26, 20238-KReg FD DisclosureAug 31, 20238-KExecutive ChangeAug 16, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 8, 20238-KShareholder VoteJul 27, 2023DEF 14AFORM DEF 14AJun 6, 20238-KExecutive ChangeJun 6, 20238-KCompany UpdateMay 19, 202310-QFORM 10-QMay 11, 20238-KResults of OperationsMay 10, 202310-KFORM 10-KMar 31, 20238-KReg FD DisclosureMar 23, 20238-KResults of OperationsMar 16, 202310-QFORM 10-QNov 9, 20228-KResults of OperationsNov 9, 20228-KExecutive ChangeOct 6, 20228-KMaterial Agreement · New Debt / ObligationSep 26, 20228-KExecutive ChangeAug 26, 202210-QFORM 10-QAug 9, 20228-KResults of OperationsAug 9, 2022SC 13GSC 13GJul 8, 2022SC 13GSC 13GJun 22, 20228-KShareholder VoteJun 15, 202210-QFORM 10-QMay 10, 20228-KResults of OperationsMay 9, 2022DEF 14AFORM DEF 14AApr 29, 20228-KAuditor ChangeApr 7, 202210-KFORM 10-KMar 31, 20228-KDelisting Notice · Company UpdateMar 18, 20228-KResults of OperationsFeb 28, 2022
Insider Activity
In the 90 days to Mar 23, 2026: 6 sold $2.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Foster Karen A.Chief Quality and Operations | Sell | 2,577 | $19.17 | $49K |
| Mar 9, 2026 | Foster Karen A.Chief Quality and Operations | Sell | 500 | $20.00 | $10K |
| Mar 5, 2026 | Foster Karen A.Chief Quality and Operations | Sell | 96,923 | $20.15 | $2.0M |
| Mar 3, 2026 | Wichterman TroyChief Financial Officer | Sell | 588 | $20.74 | $12K |
| Mar 3, 2026 | Mathew Aby J.EVP & Chief Scientific Officer | Sell | 529 | $20.74 | $11K |
| Mar 3, 2026 | Foster Karen A.Chief Quality and Operations | Sell | 418 | $20.74 | $9K |
| Mar 3, 2026 | Berard ToddChief Marketing Officer | Sell | 353 | $20.74 | $7K |
| Mar 3, 2026 | Aebersold SarahChief Human Resources Officer | Sell | 219 | $20.74 | $5K |
| Mar 3, 2026 | Werner SeanChief Technology Officer | Sell | 111 | $20.74 | $2K |
| Jan 6, 2026 | Wichterman TroyChief Financial Officer | Sell | 990 | $25.59 | $25K |
| Jan 6, 2026 | Mathew Aby J.EVP & Chief Scientific Officer | Sell | 405 | $25.59 | $10K |
| Jan 6, 2026 | Berard ToddChief Marketing Officer | Sell | 344 | $25.59 | $9K |
| Jan 6, 2026 | Foster Karen A.Chief Quality and Operations | Sell | 335 | $25.59 | $9K |
| Jan 6, 2026 | Aebersold SarahChief Human Resources Officer | Sell | 241 | $25.59 | $6K |
| Dec 15, 2025 | Duross AmyDirector | Sell | 2,000 | $24.60 | $49K |
| Dec 15, 2025 | Aebersold SarahChief Human Resources Officer | Sell | 713 | $24.46 | $17K |
| Dec 9, 2025 | Wichterman TroyChief Financial Officer | Sell | 1,033 | $25.13 | $26K |
| Dec 9, 2025 | Mathew Aby J.EVP & Chief Scientific Officer | Sell | 631 | $25.13 | $16K |
| Dec 9, 2025 | Foster Karen A.Chief Quality and Operations | Sell | 519 | $25.13 | $13K |
| Dec 9, 2025 | Berard ToddChief Marketing Officer | Sell | 358 | $25.13 | $9K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance